Luminsa, Lian Jay L.
HRN: 22-34-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2022
MUPIROCIN 2%, 15G (TUBE)
12/19/2022
12/24/2022
TOPICAL
Apply On Affected Area
8 Hrs
Bed Sore
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes